Hengehold Capital Management LLC raised its position in Danaher Corporation (NYSE:DHR – Free Report) by 3,318.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,756 shares of the conglomerate’s stock after buying an additional 50,242 shares during the period. Danaher accounts for about 0.9% of Hengehold Capital Management LLC’s investment portfolio, making the stock its 27th biggest position. Hengehold Capital Management LLC’s holdings in Danaher were worth $11,467,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Beaumont Asset Management L.L.C. bought a new position in shares of Danaher in the third quarter valued at approximately $1,685,000. Eagle Strategies LLC acquired a new position in shares of Danaher in the 3rd quarter worth approximately $2,096,000. McKinley Carter Wealth Services Inc. grew its position in Danaher by 354.6% during the 3rd quarter. McKinley Carter Wealth Services Inc. now owns 5,051 shares of the conglomerate’s stock worth $1,119,000 after acquiring an additional 3,940 shares during the last quarter. Willow Creek Capital Management Inc. grew its position in Danaher by 122.8% during the 3rd quarter. Willow Creek Capital Management Inc. now owns 5,072 shares of the conglomerate’s stock worth $1,124,000 after acquiring an additional 2,796 shares during the last quarter. Finally, Sard Wealth Management Group LLC bought a new stake in Danaher during the 3rd quarter worth approximately $1,891,000. 79.05% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on DHR shares. UBS Group initiated coverage on Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price target for the company. Barclays boosted their price objective on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. Wells Fargo & Company reduced their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Royal Bank Of Canada increased their target price on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Finally, The Goldman Sachs Group raised their target price on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $235.41.
Check Out Our Latest Analysis on DHR
Danaher Price Performance
Shares of DHR stock traded down $2.63 during trading hours on Friday, reaching $228.87. 3,516,366 shares of the company were exchanged, compared to its average volume of 4,667,069. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock’s fifty day moving average is $214.04 and its two-hundred day moving average is $195.97. The company has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a P/E/G ratio of 2.91 and a beta of 0.76.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business posted $0.77 earnings per share. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. Sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
See Also
- Five stocks we like better than Danaher
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
